Related Experiment Videos
Efficacy of bilateral pallidotomy
1New York University Center for the Study and Treatment of Movement Disorders, New York, New York, USA.
Neurosurgical Focus
|March 15, 1997
Summary
Bilateral pallidotomy offers limited additional benefit after unilateral treatment for Parkinson's disease, increasing speech risks. Chronic pallidal stimulation may be a safer alternative for bilateral procedures.
Area of Science:
- Neurosurgery
- Neurology
- Movement Disorders
Background:
- Unilateral pallidotomy is effective for Parkinson's disease with levodopa-induced dyskinesia.
- The efficacy and safety of bilateral pallidotomy remain less certain.
- Patients with bilateral symptoms or contralateral progression may require bilateral treatment.
Purpose of the Study:
- To evaluate the efficacy and safety of bilateral pallidotomy in Parkinson's disease patients.
- To assess the added benefit of a second pallidotomy procedure.
- To identify risks associated with bilateral pallidotomy.
Main Methods:
- 12 patients underwent bilateral pallidotomy, with procedures separated by at least 9 months.
- Patients were assessed using the Unified Parkinson's Disease Rating Scale (UPDRS) and Core Assessment Protocol for Intracerebral Transplantation (CAPIT) tasks.
- Assessments were conducted preoperatively and at 6 and 12 months post-procedure.
Main Results:
- The initial pallidotomy improved UPDRS and CAPIT scores by 60% (p = 0.008).
- The second pallidotomy yielded only an additional 10% improvement (p = 0.05).
- Two cases experienced worsened speech, with one transient speech arrest.
Conclusions:
- Bilateral pallidotomy has a narrow therapeutic window with diminishing returns.
- The risk of speech deficits significantly increases with bilateral procedures.
- Chronic pallidal stimulation may be a safer alternative for bilateral treatment.